| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |